We are live on !
Find out more
Bartlett & Co Portfolio holdings
AUM
$6.16B
Turnover
12.86%
1-Year Est. Return
20.29%
This Fund
S&P 500
This Quarter Est. Return
+10.4%
1 Year Est. Return
+20.29%
3 Year Est. Return
+30.84%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.16B
AUM Growth
+$590M
(+11%)
Cap. Flow
+$26M
Cap. Flow % of AUM
Cap. Flow %
0.42%
Top 10 Holdings %
Top 10 Hldgs %
30.5%
Holding
1,314
New
118
Increased
226
Reduced
290
Closed
51
Avg Time Held
3.3
years
Top 10 Avg Time Held
4.2
years
Top 20 Avg Time Held
5.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$26.9M |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$11.7M |
| 3 |
Procter & Gamble
PG
|
+$11M |
| 4 |
McCormick & Company Non-Voting
MKC
|
+$10M |
| 5 |
JPMorgan US Quality Factor ETF
JQUA
|
+$9.04M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enbridge
ENB
|
+$47.6M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$12.7M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$7.97M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$5.21M |
| 5 |
NextEra Energy
NEE
|
+$4.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.28% |
| 2 | Miscellaneous | 17.67% |
| 3 | Healthcare | 12.33% |
| 4 | Financials | 11.49% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
251
Wells Fargo
WFC
$246B
| $1.22M | 0.02% |
24,556
+3,311
| +16% | +$143K |
2013 Q2
42 quarters
|
|
252
VanEck Long Muni ETF
MLN
$700M
| $1.21M | 0.02% |
66,710
-6,510
| -9% | -$112K |
2019 Q3
17 quarters
|
|
253
Vanguard Total World Stock ETF
VT
$81.4B
| $1.18M | 0.02% |
11,432
-169
| -1% | -$16.3K |
2013 Q2
42 quarters
|
|
254
Bank of America Depository Shares Series LL
BAC.PRN
$945M
| $1.18M | 0.02% |
54,064
+1,680
| +3% | +$34.4K |
2021 Q4
8 quarters
|
|
255
IDEX
IEX
$17.2B
| $1.17M | 0.02% |
5,400
| – | – |
2019 Q3
17 quarters
|
|
256
Vanguard Ultra-Short Bond ETF
VUSB
$9.9B
| $1.15M | 0.02% |
23,256
-1,669
| -7% | -$82.2K |
2021 Q2
10 quarters
|
|
257
Vanguard Consumer Discretionary ETF
VCR
$5.89B
| $1.13M | 0.02% |
3,691
| – | – |
2022 Q4
4 quarters
|
|
258
First Solar
FSLR
$18.5B
| $1.13M | 0.02% |
6,527
-200
| -3% | -$30.6K |
2020 Q2
14 quarters
|
|
259
Truist Financial Corp Series O Preferred Stock
TFC.PRO
$424M
| $1.12M | 0.02% |
49,816
-8,040
| -14% | -$171K |
2021 Q4
8 quarters
|
|
260
Unilever
UL
$140B
| $1.1M | 0.02% |
20,178
-2,136
| -10% | -$115K |
2013 Q2
42 quarters
|
|
261
Parker-Hannifin
PH
$122B
| $1.08M | 0.02% |
2,344
-25
| -1% | -$10.4K |
2020 Q1
15 quarters
|
|
262
Cencora
COR
$64.9B
| $1.08M | 0.02% |
5,301
-200
| -4% | -$39K |
2022 Q1
7 quarters
|
|
263
PPG Industries
PPG
$23.9B
| $1.08M | 0.02% |
7,158
+23
| +0.3% | +$3.11K |
2013 Q2
42 quarters
|
|
264
PACCAR
PCAR
$57.1B
| $1.07M | 0.02% |
10,625
| – | – |
2013 Q2
42 quarters
|
|
265
Bank of New York Mellon
BNY
$96.6B
| $1.07M | 0.02% |
20,419
-1,000
| -5% | -$46.1K |
2013 Q2
42 quarters
|
|
266
Chipotle Mexican Grill
CMG
$37.8B
| $1.06M | 0.02% |
23,350
| – | – |
2013 Q2
42 quarters
|
|
267
Applied Materials
AMAT
$328B
| $1.06M | 0.02% |
6,500
| – | – |
2022 Q1
7 quarters
|
|
268
Intuitive Surgical
ISRG
$153B
| $1.02M | 0.02% |
3,017
-152
| -5% | -$45.3K |
2013 Q2
42 quarters
|
|
269
Sherwin-Williams
SHW
$80.5B
| $1.02M | 0.02% |
3,261
+51
| +2% | +$13.7K |
2019 Q2
18 quarters
|
|
270
Southern Company Series 2020C 4.20% Junior Subordinated Notes due Oct 15 2060
SOJE
$467M
| $1.02M | 0.02% |
50,766
-2,100
| -4% | -$39.7K |
2021 Q4
8 quarters
|
|
271
Veralto
VLTO
$24.5B
| $1.01M | 0.02% |
12,149
+3,262
| +37% | +$244K |
2023 Q3
1 quarter
|
|
272
Otis Worldwide
OTIS
$27B
| $995K | 0.02% |
11,100
-531
| -5% | -$44.2K |
2020 Q2
14 quarters
|
|
273
Medtronic
MDT
$119B
| $984K | 0.02% |
11,800
-937
| -7% | -$71.4K |
2013 Q2
42 quarters
|
|
274
iShares US Healthcare ETF
IYH
$4.3B
| $981K | 0.02% |
17,125
+710
| +4% | +$38.6K |
2020 Q2
14 quarters
|
|
275
Cigna
CI
$78.9B
| $975K | 0.02% |
3,256
+5
| +0.2% | +$1.46K |
2018 Q4
20 quarters
|
|
Similar funds
Bartlett & Co's Q4 2023 Portfolio in Review
As of Q4 2023, Bartlett & Co held 1,314 positions worth $6.16B, up 11% from $5.57B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Bartlett & Co's Q4 2023 filing shows 118 new, 226 increased, 290 reduced and 51 closed positions. Its largest new stake was JPMorgan US Quality Factor ETF: 201,376 shares worth $9.7M. The largest sale was Enbridge, an estimated $47.6M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Miscellaneous and Healthcare.
- Bartlett & Co's largest Q4 2023 buy was JPMorgan US Quality Factor ETF: 201,376 shares worth $9.7M.
- Bartlett & Co added most to Chevron in Q4 2023, an estimated $26.9M increase.
- Bartlett & Co's biggest Q4 2023 reduction was Enbridge, cutting an estimated $47.6M.
- Bartlett & Co fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $7.97M.
- Bartlett & Co's ten largest holdings make up 30% of its $6.16B portfolio in Q4 2023.
- Bartlett & Co opened 118 new positions and closed 51 in Q4 2023.
- Bartlett & Co's portfolio value rose 11% quarter-over-quarter to $6.16B.
Based on Bartlett & Co's 13F filing for Q4 2023, filed 8 Jan 2024.